Fetal Bovine Serum Market Projected to Reach USD 12.9 Bn at 16.5% CAGR from 2023-2033 | Marketresearch.biz Study
29 janv. 2024 02h12 HE
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The fetal bovine serum market was valued at USD 2.9 billion in 2023 with significant growth and is projected to reach USD 12.9 billion by 2033 with an...
Active Pharmaceutical Ingredient Market towards a USD 839.1 Billion by 2033 | Growth driven by advancements in healthcare sector
23 janv. 2024 07h47 HE
|
Market.Us
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Active Pharmaceutical Ingredient market size is forecasted to exceed USD 839.1 Billion by 2033, with a promising CAGR...
Furfural Market to Reach USD 817.9 million by 2031, Registering a CAGR of 5.6%: Exclusive Report by Transparency Market Research, Inc.
23 janv. 2024 03h01 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global furfural market is estimated to flourish at a CAGR of 5.6% from 2022 to 2031....
Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium
18 janv. 2024 08h45 HE
|
Elevar Therapeutics
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function as measured by both albumin-bilirubin grade and Child-Pugh...
Phenoxyethanol Market to Reach USD 329.4 million by 2031, Expanding at a CAGR of 5.1% from 2023 to 2031: Transparency Market Research, Inc.
16 janv. 2024 05h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global phenoxyethanol market is estimated to flourish at a CAGR of 5.1% from 2023 to...
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
10 janv. 2024 19h30 HE
|
Sermonix Pharmaceuticals Inc.
Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize lasofoxifene; Sermonix retains all other global rightsHenlius to facilitate...
Level Sensor Market to Reach USD 6.8 billion by 2031, Grow at a CAGR of 5.3% from 2023 to 2031 | Transparency Market Research, Inc.
10 janv. 2024 03h07 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global level sensor market is estimated to flourish at a CAGR of 5.3% from 2023 to...
Trax to Prepare Pharma Companies for California Climate Reporting Regulations
09 janv. 2024 15h23 HE
|
Trax
Trax’s existing use of European Sustainability Reporting Standards give
pharmaceutical companies a competitive advantage in reducing scope 3 emissions
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
09 janv. 2024 10h25 HE
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Dry Eye Disease Market Size Projected to Reach USD 8.7 billion by 2031, With 4.2% CAGR: Transparency Market Research, Inc.
04 janv. 2024 10h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The dry eye disease was worth US$ 6.1 billion in 2022. In 2031, it is predicted that the...